Related Experiment Videos
Mohs' micrographic surgery for basal cell carcinoma.
1Royal Victoria Infirmary, Newcastle, UK.
Clinical and Experimental Dermatology
|May 8, 1999
Summary
Mohs surgery is a recommended treatment for basal cell carcinoma (BCC), particularly for recurring or ill-defined tumors. This review critically examines the evidence supporting its claims of higher cure rates and better cosmetic outcomes.
Area of Science:
- Dermatology
- Surgical Oncology
- Oncology
Background:
- Basal cell carcinoma (BCC) is a common skin cancer.
- Mohs surgery is often the first-line treatment for recurrent or ill-defined BCC.
- The technique is based on the contiguous growth of BCC and complete tumor cell removal.
Purpose of the Study:
- To review the evidence supporting the claims of Mohs surgery for BCC.
- To evaluate the efficacy and cosmetic outcomes of Mohs surgery compared to other treatments.
Main Methods:
- Literature review of studies on Mohs surgery for BCC.
- Analysis of evidence regarding cure rates and cosmetic results.
Main Results:
- Evidence for claims of superior cure rates needs critical evaluation.
- The extent of tissue excision and subsequent cosmetic results are key considerations.
Conclusions:
- Further examination of the evidence is required to validate the purported benefits of Mohs surgery for BCC.
- The review aims to provide a balanced perspective on the technique's effectiveness and outcomes.